JP2022554348A5 - - Google Patents

Info

Publication number
JP2022554348A5
JP2022554348A5 JP2022525983A JP2022525983A JP2022554348A5 JP 2022554348 A5 JP2022554348 A5 JP 2022554348A5 JP 2022525983 A JP2022525983 A JP 2022525983A JP 2022525983 A JP2022525983 A JP 2022525983A JP 2022554348 A5 JP2022554348 A5 JP 2022554348A5
Authority
JP
Japan
Prior art keywords
cells
ccr7
attribute
composition
3cas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2022525983A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022554348A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/058985 external-priority patent/WO2021092097A1/en
Publication of JP2022554348A publication Critical patent/JP2022554348A/ja
Publication of JP2022554348A5 publication Critical patent/JP2022554348A5/ja
Ceased legal-status Critical Current

Links

JP2022525983A 2019-11-05 2020-11-04 治療用t細胞組成物の属性を決定する方法 Ceased JP2022554348A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962931194P 2019-11-05 2019-11-05
US62/931,194 2019-11-05
US201962945091P 2019-12-06 2019-12-06
US62/945,091 2019-12-06
PCT/US2020/058985 WO2021092097A1 (en) 2019-11-05 2020-11-04 Methods of determining attributes of therapeutic t cell compositions

Publications (2)

Publication Number Publication Date
JP2022554348A JP2022554348A (ja) 2022-12-28
JP2022554348A5 true JP2022554348A5 (https=) 2023-11-10

Family

ID=73599008

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022525983A Ceased JP2022554348A (ja) 2019-11-05 2020-11-04 治療用t細胞組成物の属性を決定する方法

Country Status (6)

Country Link
US (1) US20220412954A1 (https=)
EP (1) EP4055383A1 (https=)
JP (1) JP2022554348A (https=)
KR (1) KR20220131892A (https=)
CN (1) CN115087868A (https=)
WO (1) WO2021092097A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220073738A (ko) 2019-08-30 2022-06-03 주노 쎄러퓨티크스 인코퍼레이티드 세포 분류를 위한 기계 학습 방법
US12144827B2 (en) 2021-02-25 2024-11-19 Lyell Immunopharma, Inc. ROR1 targeting chimeric antigen receptor
WO2024170791A1 (en) * 2023-02-17 2024-08-22 Lumicks Ca Holding B.V. Means and methods for determining cellular avidity of primary t cells and target cells
WO2025109553A1 (en) * 2023-11-22 2025-05-30 Janssen Biotech, Inc. Manufacturing systems, methods, and ai models for reducing out of specification (oos) car t drug products
CN119648571B (zh) * 2025-02-18 2025-05-20 西湖大学 用于双光子显微镜的图像序列的处理方法、装置、系统和介质

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452773A (en) 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4795698A (en) 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
US5219740A (en) 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
AU4746590A (en) 1988-12-28 1990-08-01 Stefan Miltenyi Methods and materials for high gradient magnetic separation of biological materials
US5200084A (en) 1990-09-26 1993-04-06 Immunicon Corporation Apparatus and methods for magnetic separation
US5827642A (en) 1994-08-31 1998-10-27 Fred Hutchinson Cancer Research Center Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
DE19608753C1 (de) 1996-03-06 1997-06-26 Medigene Gmbh Transduktionssystem und seine Verwendung
US6123655A (en) 1996-04-24 2000-09-26 Fell; Claude Cell separation system with variable size chamber for the processing of biological fluids
ATE466948T1 (de) 1997-03-11 2010-05-15 Univ Minnesota Dns-basiertes transposon-system für die einführung von nucleinsäure in die dns einer zelle
CA2309000A1 (en) 1997-11-13 1999-05-27 Regents Of The University Of Minnesota Tc1-based transposon vectors
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
HK1041454B (en) 1998-12-24 2004-12-31 生物安全股份有限公司 Blood separation system particularly for concentrating hematopoietic stem cells
US7446190B2 (en) 2002-05-28 2008-11-04 Sloan-Kettering Institute For Cancer Research Nucleic acids encoding chimeric T cell receptors
PL1631788T3 (pl) 2003-05-16 2007-08-31 Univ Bruxelles Cyfrowy mikroskop holograficzny do trójwymiarowego obrazowania i sposób jego stosowania
ES2345837T3 (es) 2005-03-23 2010-10-04 Biosafe S.A. Sistema integrado para la recogida, el procesamiento y el trasplante de subgrupos de celulas, incluyendo celulas madre adultas, para medicina regenerativa.
ES2660180T3 (es) 2007-12-07 2018-03-21 Miltenyi Biotec Gmbh Sistemas y métodos para procesamiento de células
PL2222861T3 (pl) 2007-12-11 2018-04-30 The University Of North Carolina At Chapel Hill Wektory retrowirusowe ze zmodyfikowanym odcinkiem polipurynowym
TR201904484T4 (tr) 2009-11-03 2019-05-21 Hope City Transdüse T hücre seçimine yönelik kesik epiderimal büyüme faktörü reseptörü (EGFRt).
CN108107197B (zh) 2011-07-19 2020-05-08 奥维茨奥成像系统公司 用于检测和/或分类细胞样品中的癌细胞的方法和系统
BR122020002986A8 (pt) 2012-08-20 2023-04-18 Seattle Childrens Hospital Dba Seattle Childrens Res Inst Método e composições para imunoterapia celular
EP2898310B1 (en) 2012-09-20 2019-05-01 Ovizio Imaging Systems NV/SA Digital holographic microscope with fluid systems
MX370148B (es) 2012-10-02 2019-12-03 Memorial Sloan Kettering Cancer Center Composiciones y su uso para inmunoterapia.
CA2946312A1 (en) 2014-04-23 2015-10-29 Juno Therapeutics, Inc. Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
ES2987570T3 (es) 2014-11-05 2024-11-15 Juno Therapeutics Inc Métodos para la transducción y el procesamiento de células
AU2016249005B2 (en) * 2015-04-17 2022-06-16 Novartis Ag Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells
JP7623784B2 (ja) 2016-10-13 2025-01-29 ジュノー セラピューティクス インコーポレイテッド トリプトファン代謝経路調節剤を含む免疫療法の方法および組成物
JP2019532997A (ja) 2016-11-03 2019-11-14 ジュノー セラピューティクス インコーポレイテッド T細胞療法とbtk阻害剤との併用療法
CA3045339A1 (en) 2016-12-03 2018-06-07 Juno Therapeutics, Inc. Methods and compositions for use of therapeutic t cells in combination with kinase inhibitors
CN110248678A (zh) 2016-12-03 2019-09-17 朱诺治疗学股份有限公司 调节car-t细胞的方法
CN118948892A (zh) 2017-05-01 2024-11-15 朱诺治疗学股份有限公司 细胞疗法与免疫调节化合物的组合
EP3664835B1 (en) 2017-08-09 2024-10-23 Juno Therapeutics, Inc. Methods and compositions for preparing genetically engineered cells
MA50079A (fr) * 2017-09-07 2020-07-15 Juno Therapeutics Inc Procédés d'identification de caractéristiques cellulaires relatives à des réponses associées à une thérapie cellulaire
US12258580B2 (en) 2017-11-01 2025-03-25 Juno Therapeutics, Inc. Process for generating therapeutic compositions of engineered cells
US12161670B2 (en) 2017-12-08 2024-12-10 Juno Therapeutics, Inc. Phenotypic markers for cell therapy and related methods
CN119193493A (zh) 2017-12-08 2024-12-27 朱诺治疗学股份有限公司 生产工程化t细胞组合物的过程
JP7383620B2 (ja) 2018-01-31 2023-11-20 セルジーン コーポレイション 養子細胞療法およびチェックポイント阻害剤を使用する併用療法
WO2019210153A1 (en) * 2018-04-27 2019-10-31 Novartis Ag Car t cell therapies with enhanced efficacy
KR20210044736A (ko) 2018-05-03 2021-04-23 주노 쎄러퓨티크스 인코퍼레이티드 키메라 항원 수용체(car) t세포 요법과 키나제 억제제의 조합요법
US12516099B2 (en) 2018-08-09 2026-01-06 Juno Therapeutics, Inc. Processes for generating engineered cells and compositions thereof
SG11202104355SA (en) 2018-10-31 2021-05-28 Juno Therapeutics Gmbh Methods for selection and stimulation of cells and apparatus for same
ES2968737T3 (es) 2018-11-06 2024-05-13 Juno Therapeutics Inc Proceso para producir células T manipuladas genéticamente

Similar Documents

Publication Publication Date Title
JP2022554348A5 (https=)
Busch et al. Role of memory T cell subsets for adoptive immunotherapy
Crome et al. A distinct innate lymphoid cell population regulates tumor-associated T cells
Franceschetti et al. Cytokine-induced killer cells are terminallydifferentiated activated CD8 cytotoxic T-EMRA lymphocytes
JP6815992B2 (ja) キメラ抗原受容体療法に対する治療応答性を予測するバイオマーカーおよびその使用
Freud et al. Human natural killer cell development
Cieri et al. IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors
Reutner et al. CD27 expression discriminates porcine T helper cells with functionally distinct properties
Stemberger et al. Stem cell-like plasticity of naive and distinct memory CD8+ T cell subsets
US20200095547A1 (en) Methods for manufacturing t cells expressing of chimeric antigen receptors and other receptors
JP2021534245A5 (https=)
JP2018500944A5 (https=)
Takeshita et al. Polarization diversity of human CD4+ stem cell memory T cells
JP2018506995A5 (https=)
JP2023539056A5 (https=)
JP2025507581A (ja) 抗原特異的t細胞増殖のための組成物及び方法
Bhat et al. Contemplating dichotomous nature of gamma delta T cells for immunotherapy
Wang et al. Genomic expression profiling of NK cells in health and disease
Panjwani et al. Single-cell profiling aligns CD56bright and cytomegalovirus-induced adaptive natural killer cells to a naïve-memory relationship
Kretschmer et al. A single-cell perspective on memory T-cell differentiation
Shinkawa et al. CD226 identifies effector CD8+ T cells during tuberculosis and costimulates recognition of Mycobacterium tuberculosis-infected macrophages
Kawai et al. Feeder-free generation of CD4 single-positive helper T cells from human iPSCs via stage-specific modulation of Notch and TCR Signaling
Sandgaard et al. The importance of taking ART appropriately in children and adolescents with HIV-1 to reach the highest capacity of immune function later in life
Kaszubowska et al. Successful ageing of nonagenarians is related to the sensitivity of NK cells to activation
Zhao et al. CD4+ CD44v. low cells are unique peripheral precursors that are distinct from recent thymic emigrants and stem cell-like memory cells